SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMLN (DIABETES DRUGS) -- Ignore unavailable to you. Want to Upgrade?


To: LLCF who wrote (1579)1/19/1999 9:48:00 PM
From: Rudy Saucillo  Read Replies (1) | Respond to of 2173
 
Well, good question. This week's BioCentury has an article speculating that AMLN may be positioning itself for buyout by a company willing to invest in additional clinical trials building upon this subgroup analysis. I'm skeptical, as you can probably tell, but that appears to be the strategy. Rudy